Hochdosiertes Medroxyprogesteronacetat beim metastasierenden Mammakarzinom: Beziehung zwischen Krankheitsverlauf und Hormonprofilen-Reference-Cited by-同舟云学术

Hochdosiertes Medroxyprogesteronacetat beim metastasierenden Mammakarzinom: Beziehung zwischen Krankheitsverlauf und Hormonprofilen

Published:1983-06 Issue:11 Volume:61 Page:553-560
ISSN:0023-2173
Container-title:Klinische Wochenschrift
language:de
Short-container-title:Klin Wochenschr

Author:

Wander H. E.,Blossey Ch.,K�bberling J.,Nagel G. A.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Genetics (clinical),Drug Discovery,Molecular Medicine

Link

http://link.springer.com/article/10.1007/BF01486845/fulltext.html

Reference33 articles.

1. Aldinger K (1978) TSH and prolactin levels in breast cancer. Arch Intern Med 138:1638?1641

2. Barbieri RL, Osathanoudh R, Ryan KJ (1981) Danazol inhibition of steroidgenesis in the human corpus luteum. Obstet Gynecol 57:722?724

3. Blossey HC, Bartsch HH, Köbberling J (1980) Binding characteristics of medroxyprogesteroneacetate to steroid receptors in human mamma carcinoma. J Clin Chem Biochem 18:729?730

4. Blossey HC, Köbberling J (1981) The mechanism of the antitumor activity of medroxyprogesterone acetate in breast cancer. Acta Endocrinol [Suppl] 243 (Abstract 208)

5. Blossey HC, Bartsch HH, Kanne D, Köbberling J (1982a) The pharmacokinetics of high-dose medroxyprogesterone acctate (MPA) in the therapy of advanced breast cancer. Cancer Chemother Pharmacol 8:77?81

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bedeutung der Prolactin-Bestimmung bei metastasiertem Mammakarzinom;DMW - Deutsche Medizinische Wochenschrift;2008-03-25

2. Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience;Head & Neck;2000-05

3. Multiple actions of synthetic ‘progestins’ on the growth of ZR-75-1 human breast cancer cells: Anin vitro model for the simultaneous assay of androgen, progestin, estrogen, and glucocorticoid agonistic and antagonistic activities of steroids;Breast Cancer Research and Treatment;1991-01

4. Medroxyprogesterone acetate lowers plasma corticotropin and cortisol but does not suppress anterior pituitary responsiveness to human corticotropin releasing factor;Cancer;1990-11-01

5. Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth;Journal of Cancer Research and Clinical Oncology;1990-09